Article info
Clinical science
One-year outcome of intravitreal ziv-aflibercept therapy for non-responsive neovascular age-related macular degeneration
- Correspondence to Dr Jay Chhablani, LV Prasad Eye Institute, Banjara Hills, Road no. 2 Hyderabad 500034, India; jay.chhablani{at}gmail.com
Citation
One-year outcome of intravitreal ziv-aflibercept therapy for non-responsive neovascular age-related macular degeneration
Publication history
- Received February 10, 2017
- Revised April 24, 2017
- Accepted April 30, 2017
- First published June 8, 2017.
Online issue publication
December 15, 2017
Article Versions
- Previous version (8 June 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.